Chemed Corporation
CHE
$417.85
$5.551.35%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 618.80M | 646.94M | 639.99M | 606.18M | 595.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 618.80M | 646.94M | 639.99M | 606.18M | 595.88M |
| Cost of Revenue | 434.11M | 430.53M | 405.88M | 396.19M | 389.75M |
| Gross Profit | 184.69M | 216.41M | 234.12M | 209.99M | 206.13M |
| SG&A Expenses | 100.32M | 105.59M | 104.25M | 101.98M | 102.26M |
| Depreciation & Amortization | 16.26M | 16.02M | 15.83M | 15.70M | 15.71M |
| Other Operating Expenses | 26.00K | 51.00K | -288.00K | 159.00K | 37.00K |
| Total Operating Expenses | 550.71M | 552.19M | 525.67M | 514.02M | 507.76M |
| Operating Income | 68.08M | 94.76M | 114.32M | 92.16M | 88.13M |
| Income Before Tax | 71.12M | 95.67M | 120.12M | 101.03M | 93.83M |
| Income Tax Expenses | 18.62M | 23.92M | 29.80M | 25.25M | 22.94M |
| Earnings from Continuing Operations | 52.49M | 71.76M | 90.32M | 75.78M | 70.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.49M | 71.76M | 90.32M | 75.78M | 70.89M |
| EBIT | 68.08M | 94.76M | 114.32M | 92.16M | 88.13M |
| EBITDA | 84.34M | 110.78M | 125.86M | 107.85M | 103.84M |
| EPS Basic | 3.60 | 4.91 | 6.08 | 5.04 | 4.70 |
| Normalized Basic EPS | 3.05 | 4.09 | 5.07 | 4.20 | 3.88 |
| EPS Diluted | 3.57 | 4.86 | 6.03 | 5.00 | 4.65 |
| Normalized Diluted EPS | 3.02 | 4.05 | 5.03 | 4.16 | 3.85 |
| Average Basic Shares Outstanding | 14.59M | 14.62M | 14.85M | 15.03M | 15.10M |
| Average Diluted Shares Outstanding | 14.70M | 14.76M | 14.99M | 15.17M | 15.25M |
| Dividend Per Share | 0.50 | 0.50 | 0.50 | 0.50 | 0.40 |
| Payout Ratio | 13.75% | 10.21% | 8.30% | 9.88% | 8.54% |